News and Events

Johnston County Votes to Support New Expansion for Novo Nordisk

Danis Pharmaceutical Leader to Invest $65 Million in Existing Diabetes Finished Product Manufacturing Facility

Novo Nordisk, the world’s leading diabetes care company, will embark on a $65 million expansion at its Clayton campus, its third there since 2010. Headquartered in Denmark, the pharmaceutical company currently employs over 1,000 manufacturing workers in Johnston County and is likely to hire almost two dozen additional employees to staff its growing Diabetes Finished Products Facility (DFPF), which is responsible for the formulation, filling, inspection, assembly and packaging of diabetes and obesity medicines.

    Read More

Grifols to Launch $210 Million Expansion in Clayton

Creating 250 Jobs

For the second time in less than eight months, a global bio-manufacturing company has chosen Johnston County for a significant expansion. Earlier today, the Johnston County Board of Commissioners approved a 10-year incentive package that paves the way for Grifols Therapeutics Inc. to launch a $210 million expansion at its facility near Clayton. The Spain-based leader in plasma-derived medicine, already the county's largest private employer, will create 250 new jobs here over the coming decade.

" Our county is proud to take its partnership with this leading biotech company to an exciting new level," said Tony Braswell, chairman of Johnston County's Board of Commissioners, who presided over today’s unanimous vote. As Grifols meets its projections on capital investment and job creation, the county will grant up to $1,277,640 annually to the company for 10 years. " Economic development, when it takes place at this level, is all about partnerships, and it is crucial that the county be a good partner. That means being prepared to share part of the risks as well as the rewards that will grow from this."

    Read More

Novo Nordisk To Add Major New Bio-Manufacturing Operations In Clayton

$1.2 billion economic investment will add 691 employees

Johnston County will be the beneficiary of a $1.2 billion economic investment by Novo Nordisk Pharmaceutical Industries, Inc., as the Danish company launches new operations at its Clayton campus to manufacture the active ingredient for its insulin products. Novo Nordisk's decision, approved earlier today by its board of directors, brings an additional 691 bio-manufacturing jobs to the county.

"This billion-dollar decision by Novo Nordisk more than doubles the size of its North Carolina workforce and underscores the Research Triangle's global leadership in bio-manufacturing," said Governor McCrory. "When it comes to life sciences and manufacturing, North Carolina can compete - and win - against any location in the world."

    Read More